Company Overview
- Website
- apertabio.com
- Phone
- (314) 272-2645
- Employees
- 8
- Founded in
- 2017
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Recent News & Media
A Phase 2, Controlled, Double Blind, Randomized and Multicenter Study to Compare Efficacy and Safety of a Novel Topical Therapy (APT-001, Spinosad 1.8%) in Patients With Blepharitis.
- Apr 15, 2025
- ctv.veeva.com
Epigenetic Age is Minimally Correlated with Leukocyte Telomere Length in Pediatric Onset Multiple Sclerosis (P6-1.005)
- Apr 7, 2025
- neurology.org
Use tear breakup pattern to determine type of dry eye, treatment
- Sep 20, 2024
- healio.com
Cipher Pharmaceuticals Acquires Profitable Growth Dermatology Products from ParaPRO for US$89.5 Million
- Jul 29, 2024
- newswire.ca
Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US (P14-3.008)
- Dec 15, 2023
- neurology.org
Association Between Time Spent Outdoors and Risk of Multiple Sclerosis
- Dec 7, 2023
- neurology.org
Who is Aperta Biosciences
Aperta Biosciences, based in United States, specializes in the Biotechnology field. The organization has 3 professionals and annual revenue of $2.5M. For more information: apertabio.com.
Aperta Biosciences Industry Tags
Aperta Biosciences Tech Stack
Companies Similar to Aperta Biosciences
Analyze industry trends and opportunities by examining competitors and companies comparable to Aperta Biosciences, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 2 | Cambridge, MA | 2005 | |
| 3M | 7 | New York, NY | 2008 | |
| 3M | 3 | New York, NY | ||
| 3M | 2 | Knoxville, TN | 2004 | |
| 3M | 35 | Austin, TX |